Skip to main content

Featured

Israel and Lebanon Agree to 10‑Day Ceasefire as Trump Announces Breakthrough

  Israel and Lebanon Reach 10‑Day Ceasefire Following Trump Announcement Israel and Lebanon have agreed to a 10‑day ceasefire set to begin at 5 p.m. EST, according to U.S. President Donald Trump, who said the truce followed “excellent conversations” with Israeli Prime Minister Benjamin Netanyahu and Lebanese President Joseph Aoun.  The ceasefire comes after more than six weeks of intense fighting between Israel and Hezbollah, the Iran‑backed armed group operating in southern Lebanon. The conflict has resulted in over 2,000 deaths in Lebanon and displaced more than a million residents, while Israel has maintained a 10‑kilometre security zone in southern Lebanon. Trump stated that both leaders agreed to begin the truce to pursue peace, adding that he plans to invite them to the White House for the first direct talks between the two countries since 1983. Lebanese officials have welcomed the ceasefire, though Hezbollah has said its adherence depends on Israel halting all attacks....
Post a Comment
Read more

article

Labels

Stock Futures Steady as Investors Await Fresh Jobs Data

U.S. stock futures were little changed on Thursday as Wall Street attempted to recover from recent declines. Futures tied to the S&P 500 were flat, while Nasdaq futures rose slightly. Dow Jones Industrial Average futures fell marginally.

Labor Market Update: Today’s spotlight is on the release of the report on initial weekly jobless claims. A positive number could reassure traders about the state of the jobs market, while a negative one may introduce more turbulence. Last week’s sluggish non-farm payrolls update was one of the catalysts for recent declines.

Individual Movers:

  • Nvidia (NVDA): The AI giant’s stock is in focus after a back-and-forth day left it down another 5%.
  • Eli Lilly (LLY): The company’s stock soared over 10% in premarket trading after boosting its annual revenue and profit forecasts on strong weight-loss drug sales.


Labels:

Comments

Post a Comment